BUND FINANCE

BUND FINANCE › Stocks › TEVA

Teva Pharmaceutical Industries Limited (TEVA)

NYSE · Stock price, chart and technical analysis

US$42.23-0.3900 (-0.92%)

Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed

Open the live chartSee Technicals⏱ Analyze entryQuarterly earnings📅 See in calendar💬 Explain this move⇄ ComparePractice in the Simulator

Key stats

Previous closeUS$42.62
OpenUS$42.75
Day rangeUS$42.04 – US$43.09
52-week rangeUS$24.01 – US$44.57
Market capUS$49.28B
Volume8.86M
50-day averageUS$40.42
200-day averageUS$35.18
Beta0.84

Quick technical read

This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it

Fundamentals Annual

Fiscal year20212022202320242025
RevenueUS$15.9BUS$14.9BUS$15.8BUS$16.5BUS$17.3B
Net incomeUS$417.0M−US$2.4B−US$559.0M−US$1.6BUS$1.4B
EPS (diluted)0.38-2.20-0.50-1.451.20
Gross margin47.8%46.7%48.3%48.7%51.8%
Operating margin10.8%-14.7%2.7%-1.8%12.5%
Net margin2.6%-16.4%-3.5%-9.9%8.2%
Free cash flowUS$236.0MUS$1.0BUS$842.0MUS$749.0MUS$1.1B
Total debtUS$23.5BUS$21.6BUS$20.2BUS$18.1BUS$17.4B
CashUS$2.2BUS$2.8BUS$3.2BUS$3.3BUS$3.6B

Compound annual growth: revenue 2.1% · net income 35.6% (4 years).

Valuation: today, its history and its sector

Today5-year averageSector median (Healthcare)
P/E98.2x23.2x27.1x
EV / EBITDA30.6x12.5x16.5x
Operating margin10.5%—3.6%
Net margin2.9%—-0.0%
Debt / equity4.02—0.58

Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.

About Teva Pharmaceutical Industries Limited

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CountryIL
CEORichard D. Francis
Employees32,008
IPO date1982-02-16

Teva Pharmaceutical Industries Limited functions as a global pharmaceutical enterprise, involved in the conception, manufacturing, marketing, and provision of a broad spectrum of generic, specialty, and biopharmaceutical products throughout North America, Europe, and various international markets. The company's diverse product range includes sterile items, hormones, potent drugs, and cytotoxic agents, available in numerous forms like tablets, capsules, injectable solutions, inhalable preparations, liquids, transdermal patches, topical ointments, and creams. Additionally, Teva develops, produces, and sells active pharmaceutical ingredients (APIs). The firm prioritizes several key therapeutic …

www.tevapharm.com

Other stocks on BUND FINANCE

Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice